Farallon Capital Management
Latest statistics and disclosures from Farallon Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, PXD, UNH, IQV, EXEL, and represent 41.39% of Farallon Capital Management's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$6.0B), UNH (+$842M), IQV (+$717M), EXEL (+$633M), CRM (+$588M), ARMK (+$580M), NDAQ (+$532M), MSFT (+$510M), GOOG (+$508M), TRU (+$507M).
- Started 166 new stock positions in BCSAW, BSX, ROIV, INSP, FBRX, JWSM.WS, IDYA, SRPT, BEAM, HUM.
- Reduced shares in these 4 stocks: stock (-$202M), Karuna Therapeutics Ord (-$165M), Splunk (-$23M), Sovos Brands (-$9.2M).
- Sold out of its positions in Karuna Therapeutics Ord, Sovos Brands, stock, Splunk.
- Farallon Capital Management was a net buyer of stock by $21B.
- Farallon Capital Management has $22B in assets under management (AUM), dropping by 1909.13%.
- Central Index Key (CIK): 0000909661
Tip: Access up to 7 years of quarterly data
Positions held by Farallon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 167 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 27.3 | $6.0B | NEW | 12M | 523.07 |
|
| Pioneer Natural Resources (PXD) | 4.2 | $924M | +12% | 3.5M | 262.50 |
|
| UnitedHealth (UNH) | 3.8 | $842M | NEW | 1.7M | 494.70 |
|
| Iqvia Holdings (IQV) | 3.2 | $717M | NEW | 2.8M | 252.89 |
|
| Exelixis (EXEL) | 2.9 | $633M | NEW | 27M | 23.73 |
|
| salesforce (CRM) | 2.7 | $588M | NEW | 2.0M | 301.18 |
|
| Aramark Hldgs (ARMK) | 2.6 | $580M | NEW | 18M | 32.52 |
|
| Nasdaq Omx (NDAQ) | 2.4 | $532M | NEW | 8.4M | 63.10 |
|
| Microsoft Corporation (MSFT) | 2.3 | $510M | NEW | 1.2M | 420.72 |
|
| Alphabet Cap Stk Cl C (GOOG) | 2.3 | $508M | NEW | 3.3M | 152.26 |
|
| Transunion (TRU) | 2.3 | $507M | NEW | 6.4M | 79.80 |
|
| New York Times Cl A (NYT) | 2.2 | $484M | NEW | 11M | 43.22 |
|
| Ishares Tr Ishares Biotech Put Option (IBB) | 2.2 | $480M | NEW | 3.5M | 137.22 |
|
| Thermo Fisher Scientific (TMO) | 2.1 | $464M | NEW | 797k | 581.21 |
|
| Wabtec Corporation (WAB) | 1.9 | $431M | NEW | 3.0M | 145.68 |
|
| Cbre Group Cl A (CBRE) | 1.8 | $407M | NEW | 4.2M | 97.24 |
|
| Natera (NTRA) | 1.6 | $359M | NEW | 3.9M | 91.46 |
|
| Intuit (INTU) | 1.6 | $349M | NEW | 537k | 650.00 |
|
| S&p Global (SPGI) | 1.5 | $338M | NEW | 794k | 425.45 |
|
| Sarepta Therapeutics (SRPT) | 1.4 | $318M | NEW | 2.5M | 129.46 |
|
| Boston Scientific Corporation (BSX) | 1.4 | $315M | NEW | 4.6M | 68.49 |
|
| Analog Devices (ADI) | 1.4 | $304M | NEW | 1.5M | 197.79 |
|
| Servicenow (NOW) | 1.4 | $301M | NEW | 395k | 762.40 |
|
| Airbnb Com Cl A (ABNB) | 1.2 | $265M | NEW | 1.6M | 164.96 |
|
| Sherwin-Williams Company (SHW) | 1.2 | $262M | NEW | 754k | 347.33 |
|
| CoStar (CSGP) | 1.1 | $251M | NEW | 2.6M | 96.60 |
|
| Mastercard Incorporated Cl A (MA) | 1.1 | $247M | NEW | 513k | 481.57 |
|
| Revolution Medicines (RVMD) | 1.1 | $242M | NEW | 7.5M | 32.23 |
|
| Howmet Aerospace (HWM) | 1.1 | $233M | NEW | 3.4M | 68.43 |
|
| Masimo Corporation (MASI) | 1.0 | $219M | NEW | 1.5M | 146.85 |
|
| Aon Shs Cl A (AON) | 1.0 | $211M | NEW | 632k | 333.72 |
|
| Centene Corporation (CNC) | 0.9 | $205M | NEW | 2.6M | 78.48 |
|
| Full Truck Alliance Sponsored Ads (YMM) | 0.9 | $191M | NEW | 26M | 7.27 |
|
| Visa Com Cl A (V) | 0.9 | $190M | NEW | 681k | 279.08 |
|
| Protagonist Therapeutics (PTGX) | 0.8 | $166M | NEW | 5.7M | 28.93 |
|
| Agios Pharmaceuticals (AGIO) | 0.7 | $164M | NEW | 5.6M | 29.24 |
|
| Iqiyi Note 4.000%12/1 (Principal) | 0.7 | $161M | NEW | 163M | 0.99 |
|
| Beam Therapeutics (BEAM) | 0.7 | $149M | NEW | 4.5M | 33.04 |
|
| Inspire Med Sys (INSP) | 0.6 | $135M | NEW | 627k | 214.79 |
|
| Longboard Pharmaceuticals In (LBPH) | 0.6 | $125M | NEW | 5.8M | 21.60 |
|
| Sunrun Note 2/0 (Principal) | 0.5 | $113M | NEW | 131M | 0.87 |
|
| Astrazeneca Sponsored Adr (AZN) | 0.4 | $99M | NEW | 1.5M | 67.75 |
|
| Vestis Corporation Com Shs (VSTS) | 0.4 | $95M | NEW | 4.9M | 19.27 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.4 | $92M | NEW | 1.5M | 62.24 |
|
| Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC) | 0.4 | $85M | NEW | 1.3M | 63.17 |
|
| AmerisourceBergen (COR) | 0.4 | $81M | NEW | 334k | 242.99 |
|
| Zto Express Cayman Note 1.500% 9/0 (Principal) | 0.3 | $73M | NEW | 75M | 0.98 |
|
| Tenet Healthcare Corp Com New (THC) | 0.3 | $67M | NEW | 637k | 105.11 |
|
| Silicon Motion Technology Sponsored Adr (SIMO) | 0.3 | $66M | NEW | 855k | 76.94 |
|
| Ke Hldgs Sponsored Ads (BEKE) | 0.3 | $65M | NEW | 4.7M | 13.73 |
|
| Icon SHS (ICLR) | 0.3 | $60M | NEW | 180k | 335.95 |
|
| New Oriental Ed & Technology Spon Adr (EDU) | 0.2 | $53M | NEW | 615k | 86.82 |
|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 0.2 | $47M | NEW | 500k | 94.89 |
|
| Biohaven (BHVN) | 0.2 | $44M | NEW | 799k | 54.69 |
|
| Enanta Pharmaceuticals (ENTA) | 0.2 | $37M | NEW | 2.1M | 17.46 |
|
| Evolent Health Cl A (EVH) | 0.2 | $34M | NEW | 1.0M | 32.79 |
|
| Ionis Pharmaceuticals (IONS) | 0.1 | $32M | NEW | 734k | 43.35 |
|
| Liquidia Corporation Com New (LQDA) | 0.1 | $30M | NEW | 2.1M | 14.75 |
|
| Hims & Hers Health Com Cl A (HIMS) | 0.1 | $26M | NEW | 1.7M | 15.47 |
|
| Vaxcyte (PCVX) | 0.1 | $26M | NEW | 377k | 68.31 |
|
| United Therapeutics Corporation (UTHR) | 0.1 | $25M | NEW | 110k | 229.72 |
|
| Geron Corporation (GERN) | 0.1 | $25M | NEW | 7.5M | 3.30 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 0.1 | $24M | NEW | 329k | 72.36 |
|
| Progyny (PGNY) | 0.1 | $23M | NEW | 593k | 38.15 |
|
| Voyager Therapeutics (VYGR) | 0.1 | $21M | NEW | 2.3M | 9.31 |
|
| PG&E Corporation (PCG) | 0.1 | $21M | NEW | 1.3M | 16.76 |
|
| Apogee Therapeutics (APGE) | 0.1 | $20M | NEW | 305k | 66.45 |
|
| Elevation Oncology (ELEV) | 0.1 | $20M | NEW | 3.9M | 5.13 |
|
| Humana (HUM) | 0.1 | $18M | NEW | 52k | 346.72 |
|
| Spyre Therapeutics Com New (SYRE) | 0.1 | $18M | NEW | 466k | 37.93 |
|
| Arcutis Biotherapeutics (ARQT) | 0.1 | $18M | NEW | 1.8M | 9.91 |
|
| Ventyx Biosciences (VTYX) | 0.1 | $17M | NEW | 3.2M | 5.50 |
|
| Zymeworks Del (ZYME) | 0.1 | $17M | NEW | 1.6M | 10.52 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.1 | $17M | NEW | 109k | 151.17 |
|
| Intra Cellular Therapies (ITCI) | 0.1 | $16M | NEW | 231k | 69.20 |
|
| Tal Education Group Sponsored Ads (TAL) | 0.1 | $16M | NEW | 1.4M | 11.35 |
|
| Avidity Biosciences Ord (RNA) | 0.1 | $16M | NEW | 606k | 25.52 |
|
| Immunome (IMNM) | 0.1 | $15M | NEW | 594k | 24.68 |
|
| Metagenomi | 0.1 | $14M | NEW | 1.3M | 10.55 |
|
| Pacific Biosciences of California (PACB) | 0.1 | $14M | NEW | 3.8M | 3.75 |
|
| Savara (SVRA) | 0.1 | $12M | NEW | 2.4M | 4.98 |
|
| Quanterix Ord (QTRX) | 0.1 | $11M | NEW | 471k | 23.56 |
|
| Screaming Eagle Acquisitn Class A Ord Shs (SCRM) | 0.0 | $11M | NEW | 1.0M | 10.70 |
|
| Joyy Note 1.375% 6/1 (Principal) | 0.0 | $10M | NEW | 10M | 0.99 |
|
| Roivant Sciences SHS (ROIV) | 0.0 | $9.5M | NEW | 899k | 10.54 |
|
| Rio Tinto Sponsored Adr (RIO) | 0.0 | $8.8M | NEW | 138k | 63.74 |
|
| Cazoo Group Cl A (CZOO) | 0.0 | $8.6M | NEW | 714k | 12.00 |
|
| Bruker Corporation (BRKR) | 0.0 | $7.8M | NEW | 83k | 93.94 |
|
| Gossamer Bio (GOSS) | 0.0 | $7.2M | NEW | 6.1M | 1.18 |
|
| Cytokinetics Com New (CYTK) | 0.0 | $7.2M | NEW | 102k | 70.11 |
|
| Helix Acquisition Corp Ii Cl A Ord Shs | 0.0 | $6.2M | NEW | 600k | 10.35 |
|
| Novavax Com New (NVAX) | 0.0 | $5.4M | NEW | 1.1M | 4.78 |
|
| Prime Medicine (PRME) | 0.0 | $5.3M | NEW | 750k | 7.00 |
|
| Altimmune Com New (ALT) | 0.0 | $4.8M | NEW | 470k | 10.18 |
|
| GDS HLDGS Sponsored Ads (GDS) | 0.0 | $4.7M | NEW | 710k | 6.65 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.0 | $4.6M | NEW | 99k | 46.69 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.0 | $4.2M | NEW | 371k | 11.30 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.0 | $3.3M | NEW | 1.2M | 2.84 |
|
| Swiftmerge Acquisition Corp Class A Ord Shs (IVCP) | 0.0 | $3.2M | NEW | 300k | 10.82 |
|
| Cogent Biosciences (COGT) | 0.0 | $3.1M | NEW | 462k | 6.72 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.0 | $3.1M | NEW | 50k | 61.02 |
|
| Berenson Acquisition Corp I Cl A Com (BACA) | 0.0 | $3.0M | NEW | 286k | 10.35 |
|
| Arrivent Biopharma | 0.0 | $2.7M | NEW | 152k | 17.86 |
|
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $2.3M | NEW | 200k | 11.27 |
|
| Metals Acquisition Ord Shs (MTAL) | 0.0 | $2.0M | NEW | 158k | 12.85 |
|
| Metals Acquisition *w Exp 06/15/202 (MTAL.WS) | 0.0 | $1.7M | NEW | 825k | 2.12 |
|
| Summit Midstream Partners Com Unit Ltd (SMLP) | 0.0 | $1.6M | NEW | 58k | 28.07 |
|
| Marblegate Acquisition Corp Com Cl A (GATE) | 0.0 | $1.6M | NEW | 150k | 10.46 |
|
| Cara Therapeutics (CARA) | 0.0 | $1.4M | NEW | 1.6M | 0.91 |
|
| Forte Biosciences (FBRX) | 0.0 | $1.3M | NEW | 1.8M | 0.70 |
|
| Grindr *w Exp 11/18/202 (GRND.WS) | 0.0 | $1.2M | NEW | 540k | 2.31 |
|
| Soleno Therapeutics (SLNO) | 0.0 | $1.2M | NEW | 28k | 42.80 |
|
| Vnet Group Sponsored Ads A (VNET) | 0.0 | $1.0M | NEW | 650k | 1.55 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.0 | $886k | NEW | 3.3k | 267.04 |
|
| Sage Therapeutics (SAGE) | 0.0 | $802k | NEW | 43k | 18.74 |
|
| Intuitive Machines *w Exp 99/99/999 (LUNRW) | 0.0 | $772k | NEW | 441k | 1.75 |
|
| Lufax Holding Sponsored Adr (LU) | 0.0 | $633k | NEW | 150k | 4.22 |
|
| Iovance Biotherapeutics (IOVA) | 0.0 | $385k | NEW | 26k | 14.82 |
|
| Blueprint Medicines (BPMC) | 0.0 | $379k | NEW | 4.0k | 94.86 |
|
| Krystal Biotech (KRYS) | 0.0 | $356k | NEW | 2.0k | 177.93 |
|
| Apellis Pharmaceuticals (APLS) | 0.0 | $353k | NEW | 6.0k | 58.78 |
|
| Hca Holdings (HCA) | 0.0 | $334k | NEW | 1.0k | 333.53 |
|
| Axsome Therapeutics (AXSM) | 0.0 | $319k | NEW | 4.0k | 79.80 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.0 | $299k | NEW | 2.0k | 149.45 |
|
| Arcellx Common Stock (ACLX) | 0.0 | $278k | NEW | 4.0k | 69.55 |
|
| Chemed Corp Com Stk (CHE) | 0.0 | $257k | NEW | 400.00 | 641.93 |
|
| Encompass Health Corp (EHC) | 0.0 | $248k | NEW | 3.0k | 82.58 |
|
| Springworks Therapeutics (SWTX) | 0.0 | $246k | NEW | 5.0k | 49.22 |
|
| Glaukos (GKOS) | 0.0 | $245k | NEW | 2.6k | 94.29 |
|
| Brightspring Health Svcs | 0.0 | $239k | NEW | 22k | 10.87 |
|
| Syndax Pharmaceuticals (SNDX) | 0.0 | $238k | NEW | 10k | 23.80 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.0 | $234k | NEW | 5.0k | 46.81 |
|
| Alpine Immune Sciences (ALPN) | 0.0 | $234k | NEW | 5.9k | 39.64 |
|
| C4 Therapeutics Com Stk (CCCC) | 0.0 | $229k | NEW | 28k | 8.17 |
|
| Healthequity (HQY) | 0.0 | $229k | NEW | 2.8k | 81.63 |
|
| Merit Medical Systems (MMSI) | 0.0 | $227k | NEW | 3.0k | 75.75 |
|
| Acadia Healthcare (ACHC) | 0.0 | $222k | NEW | 2.8k | 79.22 |
|
| Ideaya Biosciences (IDYA) | 0.0 | $219k | NEW | 5.0k | 43.88 |
|
| Sabra Health Care REIT (SBRA) | 0.0 | $207k | NEW | 14k | 14.77 |
|
| R1 RCM (RCM) | 0.0 | $206k | NEW | 16k | 12.88 |
|
| Amicus Therapeutics (FOLD) | 0.0 | $189k | NEW | 16k | 11.78 |
|
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 0.0 | $187k | NEW | 28k | 6.68 |
|
| Ardelyx (ARDX) | 0.0 | $168k | NEW | 23k | 7.30 |
|
| Oscar Health Cl A (OSCR) | 0.0 | $164k | NEW | 11k | 14.87 |
|
| Screaming Eagle Acquisitn *w Exp 99/99/999 (SCRMW) | 0.0 | $158k | NEW | 333k | 0.47 |
|
| Beyond Meat (BYND) | 0.0 | $157k | NEW | 19k | 8.28 |
|
| Sep Acquisition Corp *w Exp 99/99/999 (SEPAW) | 0.0 | $147k | NEW | 866k | 0.17 |
|
| Sdcl Edge Acquisition Corp *w Exp 99/99/999 (SEDA.WS) | 0.0 | $121k | NEW | 866k | 0.14 |
|
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $113k | NEW | 13k | 8.71 |
|
| Solid Power *w Exp 12/08/202 (SLDPW) | 0.0 | $85k | NEW | 405k | 0.21 |
|
| Aeon Biopharma *w Exp 07/21/202 (AEON.WS) | 0.0 | $73k | NEW | 50k | 1.45 |
|
| Churchill Capital Corp Vii *w Exp 02/29/202 (CVIIW) | 0.0 | $64k | NEW | 200k | 0.32 |
|
| Swiftmerge Acquisition Corp *w Exp 12/13/202 (IVCPW) | 0.0 | $55k | NEW | 990k | 0.06 |
|
| Gores Holdings Ix *w Exp 01/14/202 (GHIXW) | 0.0 | $47k | NEW | 167k | 0.28 |
|
| Jaws Mustang Acquisition Cor *w Exp 01/30/202 (JWSM.WS) | 0.0 | $43k | NEW | 200k | 0.21 |
|
| Kensington Capital Acquisiti *w Exp 99/99/999 (KCGI.WS) | 0.0 | $35k | NEW | 581k | 0.06 |
|
| Vast Renewables *w Exp 07/01/202 (VSTEW) | 0.0 | $32k | NEW | 450k | 0.07 |
|
| Marblegate Acquisition Corp *w Exp 08/31/202 (GATEW) | 0.0 | $26k | NEW | 1.5M | 0.02 |
|
| Rcf Acquisition Corp *w Exp 99/99/999 (RCFA.WS) | 0.0 | $22k | NEW | 300k | 0.07 |
|
| Lamf Global Ventures Corp I *w Exp 99/99/999 (LGVCW) | 0.0 | $20k | NEW | 200k | 0.10 |
|
| Nvni Group *w Exp 11/01/202 (NVNIW) | 0.0 | $20k | NEW | 375k | 0.05 |
|
| Revolution Medicines *w Exp 12/17/202 (RVMDW) | 0.0 | $19k | NEW | 120k | 0.16 |
|
| Cartica Acquisition Corp *w Exp 04/30/202 (CITEW) | 0.0 | $17k | NEW | 175k | 0.10 |
|
| Blockchain Coinvstrs Acq Crp *w Exp 11/01/202 (BCSAW) | 0.0 | $6.3k | NEW | 150k | 0.04 |
|
| Rigetti Computing *w Exp 99/99/999 (RGTIW) | 0.0 | $5.6k | NEW | 23k | 0.24 |
|
| Slam Corp *w Exp 99/99/999 (SLAMW) | 0.0 | $3.2k | NEW | 18k | 0.18 |
|
| Movella Holdings *w Exp 02/10/202 (MVLAW) | 0.0 | $945.000000 | NEW | 150k | 0.01 |
|
Past Filings by Farallon Capital Management
SEC 13F filings are viewable for Farallon Capital Management going back to 2010
- Farallon Capital Management 2024 Q1 filed May 15, 2024
- Farallon Capital Management 2023 Q3 amended filed May 15, 2024
- Farallon Capital Management 2023 Q4 amended filed May 15, 2024
- Farallon Capital Management 2023 Q3 amended filed Feb. 12, 2024
- Farallon Capital Management 2023 Q3 filed Nov. 14, 2023
- Farallon Capital Management 2022 Q1 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q2 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q3 amended filed Nov. 14, 2023
- Farallon Capital Management 2022 Q4 amended filed Nov. 14, 2023
- Farallon Capital Management 2023 Q1 amended filed Nov. 14, 2023
- Farallon Capital Management 2023 Q2 amended filed Nov. 14, 2023
- Farallon Capital Management 2023 Q2 amended filed Oct. 26, 2023
- Farallon Capital Management 2023 Q2 filed Aug. 14, 2023
- Farallon Capital Management 2023 Q1 amended filed Aug. 14, 2023
- Farallon Capital Management 2023 Q1 filed May 15, 2023
- Farallon Capital Management 2021 Q2 amended filed May 15, 2023